Robin Healthcare is a technology company.
Robin Healthcare has raised $62.0M across 2 funding rounds.
Robin Healthcare has raised $62.0M in total across 2 funding rounds.
Robin Healthcare is a technology company founded in 2017 that builds The Robin Assistant™, an ambient clinical documentation platform combining AI and human expertise to automate medical note-taking in exam rooms.[1][2][3] It serves physicians and healthcare providers by solving the problem of administrative burdens—such as insurer compliance, billing, and liability documentation—that consume up to 90 minutes daily per doctor, allowing them to focus on patient care without typing, clicking, or dictating.[1][3] The platform integrates seamlessly into electronic medical records (EMRs), uses military-grade encryption, ensures HIPAA and SOC 2 compliance, and guarantees its documentation in audits, often at little to no net cost.[1] Robin has shown strong growth, including 300% compounded annual growth as of its 2021 Series B funding round where it raised $50 million, and employs 501-1000 people as an IT services firm in healthcare.[1][2]
Robin Healthcare emerged from stealth mode in May 2018, headquartered in Berkeley, California, with a mission to remove barriers to health using technology and human expertise.[2][3] It was co-founded by Noah Auerhahn (CEO), a repeat entrepreneur who previously built and sold Extrabux (San Diego's fourth-fastest-growing company, acquired by Ebates in 2013) and Essia Health, alongside a team with clinical training from UCSF and UCLA, informatics and machine learning experience from Duke, and natural language processing expertise from UC Berkeley.[1][3] The idea stemmed from founders' recognition of medicine's complexity and AI's limitations in clinical documentation, aiming to assist without interrupting care—drawing from their clinical and technical backgrounds to address physicians' pain points like tedious data capture.[3] Early traction included nationwide availability upon launch and rapid adoption, culminating in the 2021 $50M Series B led by Scale Venture Partners to scale physician empowerment.[1]
Robin rides the AI-healthcare administration wave, targeting the $15B+ U.S. clinical documentation market strained by regulatory demands, physician burnout (2+ hours daily on notes), and value-based care shifts.[1][3] Timing aligns with post-pandemic telehealth/ambient AI adoption (e.g., Nuance Dragon expansions) and insurer pressures for proof of quality care, where Robin disrupts by humanizing AI to meet compliance without workflow disruption.[1] Favorable forces include labor shortages amplifying admin burdens and AI maturity enabling hybrid models; Robin influences the ecosystem by standardizing data for better analytics/billing, empowering independent practices against consolidation, and paving the way for scalable, human-centered health tech.[1][3]
Robin is poised to expand amid rising AI scribe demand (market projected to grow 15-20% annually), potentially capturing share through audit guarantees and EMR partnerships while iterating on multi-modal AI for specialties.[1] Trends like generative AI advancements and regulatory pushes for efficiency will accelerate adoption, though competition from pure-play scribes (e.g., Nabla, Suki) tests its hybrid edge. Its influence may evolve toward platform status, enabling broader practice management tools and data insights, solidifying its role in freeing physicians to prioritize care over paperwork.[1][3] This positions Robin as a key enabler in a more autonomous, patient-centric healthcare future.
Robin Healthcare has raised $62.0M in total across 2 funding rounds.
Robin Healthcare's investors include Allegion Ventures, Brainchild, DST Global, Learn Capital, Maverick Capital, Norwest Venture Partners, Otherwise Fund, Revolution, Scale Venture Partners, Silicon Valley Connect, Tola Capital, Union Square Ventures.
Robin Healthcare has raised $62.0M across 2 funding rounds. Most recently, it raised $50.0M Series B in December 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 1, 2021 | $50.0M Series B | Allegion Ventures, Brainchild, DST Global, Learn Capital, Maverick Capital, Norwest Venture Partners, Otherwise Fund, Revolution, Scale Venture Partners, Silicon Valley Connect, Tola Capital, Union Square Ventures, Webb Investment Network, Y Combinator, Esther Dyson, Jeff Hammerbacher, Joshua Schachter, Lisa Gansky, Sam Altman | |
| Sep 1, 2019 | $12.0M Series A | Brainchild, DST Global, Learn Capital, Maverick Capital, Norwest Venture Partners, Otherwise Fund, Revolution, Silicon Valley Connect, Union Square Ventures, Webb Investment Network, Y Combinator, Esther Dyson, Jeff Hammerbacher, Joshua Schachter, Lisa Gansky, Sam Altman |